Continued product development and R&D
First written in FY2021-Q3. 10 of 21 entries say "Advanced", first in FY2021. Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Company's total research and development expenses for the fiscal year were ¥187.813 million. Since March 2026, the Company has been conducting joint research and development on quantum dot comb lasers and related optoelectronic technologies with Taiwan's Industrial Technology Research Institute (ITRI) and the Arakawa Laboratory at The University of Tokyo.」
Research and development expenses were ¥187.813 million, and the Company began joint research and development with ITRI and the Arakawa Laboratory at The University of Tokyo on quantum dot comb lasers and related technologies. - FY2026-H1AdvancedAnnual report
「Specific initiatives included beginning to accept orders for the all-in-one compact visible laser product “Lantana,” continuing development of compact visible lasers with new wavelengths, ultrafast DFB lasers for semiconductor inspection and next-generation eyewear, including an eye-tracking drive system, while promoting sales of existing laser products and accepting commissioned development projects. Research and development expenses for the six-month period were ¥111.172 million, up 60.2% year on year.」
The filing reports the start of order acceptance for Lantana, continued development of next-generation eyewear and other products, and promotion of commissioned development projects. Research and development expenses also increased 60.2% year on year. - FY2025AdvancedAnnual report
「The Company's total research and development expenses for the fiscal year were ¥173.785 million. The Company completed a prototype of “Lantana,” an all-in-one compact visible laser with a built-in driver that is ready to use on a plug-and-play basis.」
The Company incurred research and development expenses of ¥173.785 million. The filing reports completion of the Lantana prototype, prototyping to improve the characteristics of 1030nm DFB lasers, AR glasses prototyping and continued improvements to the eye-tracking drive system. - FY2025-H1RestatedAnnual report
「Research and development expenses for the six-month period were ¥69.387 million, up 1.0% year on year. There were no material changes in the Company's research and development activities during the six-month period from the content described in “Part II. Business Overview, 6. Research and Development Activities” of the securities report filed on 28 June 2024.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥69.387 million, up 1.0% year on year. - FY2024AdvancedAnnual report
「Conducted prototyping using a change in wafer size from 3 inches to 4 inches to reduce the cost of quantum dot lasers for silicon photonics.」
The Company incurred research and development expenses of ¥177.023 million and conducted prototyping to increase the wafer size for quantum dot lasers, improve the characteristics of 1064nm DFB lasers, develop VR glasses and develop an eye-tracking drive system. - FY2024-Q3RestatedAnnual report
「Research and development expenses for the nine-month period were ¥118.518 million, down 27.4% year on year. There were no material changes in the Company's research and development activities during the nine-month period from the content described in “Part II. Business Overview, 6. Research and Development Activities” of the securities report filed on 27 June 2023.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥118.518 million, down 27.4% year on year. - FY2024-Q2RestatedAnnual report
「Research and development expenses for the six-month period were ¥68.671 million, down 38.6% year on year. There were no material changes in the Company's research and development activities during the six-month period from the content described in “Part II. Business Overview, 6. Research and Development Activities” of the securities report filed on 27 June 2023.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥68.671 million, down 38.6% year on year. - FY2024-Q1RestatedAnnual report
「Research and development expenses for the three-month period were ¥25.169 million, down 38.9% year on year. There were no material changes in the Company's research and development activities during the three-month period from the content described in “Part II. Business Overview, 5. Research and Development Activities” of the securities report filed on 27 June 2023.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥25.169 million, down 38.9% year on year. - FY2023AdvancedAnnual report
「Completed qualification testing of mass-produced products using a modified wafer process line to reduce the cost of quantum dot lasers for silicon photonics.」
The Company incurred research and development expenses of ¥232.804 million and completed qualification testing of mass-produced quantum dot lasers, in addition to progressing to product commercialization and sales launches for ON HAND, NEOVIEWER and MEOCHECK. - FY2023-Q3RestatedAnnual report
「Research and development expenses for the nine-month period were ¥163.234 million, up 16.8% year on year. There were no material changes in the Company's research and development activities during the nine-month period from the content described in “Part II. Business Overview, 5. Research and Development Activities” of the securities report filed on 28 June 2022.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥163.234 million, up 16.8% year on year. - FY2023-Q2RestatedAnnual report
「Research and development expenses for the six-month period were ¥111.857 million, down 1% year on year. There were no material changes in the Company's research and development activities during the six-month period from the content described in “Part II. Business Overview, 5. Research and Development Activities” of the securities report filed on 28 June 2022.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥111.857 million, down 1% year on year. - FY2023-Q1RestatedAnnual report
「Research and development expenses for the three-month period were ¥41.200 million, down 40.7% year on year. There were no material changes in the Company's research and development activities during the three-month period from the content described in “Part II. Business Overview, 5. Research and Development Activities” of the securities report filed on 28 June 2022.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥41.200 million, down 40.7% year on year. - FY2022AdvancedAnnual report
「Completed pre-mass-production prototyping using a modified wafer process line to reduce the cost of quantum dot lasers for silicon photonics.」
Research and development included completion of pre-mass-production prototyping of quantum dot lasers, proof-of-concept prototyping of drivers for compact multicolor lasers, pre-mass-production prototyping of ON HAND and SUPER CAPTURE, and proof-of-concept prototyping of MEOCHECK. - FY2022-Q3RestatedAnnual report
「Research and development expenses for the nine-month period were ¥139.756 million, up 44.0% year on year. There were no material changes in the Company's research and development activities during the nine-month period from the content described in “Part II. Business Overview, 5. Research and Development Activities” of the securities report filed on 25 June 2021.」
The filing continues to state that there were no material changes in the research and development activities. Research and development expenses were ¥139.756 million, up 44.0% year on year. - FY2022-Q2RestatedAnnual report
「Research and development expenses for the six-month period were ¥112.854 million, up 206.9% year on year. There were no material changes in the Company's research and development activities during the six-month period.」
The filing continues to state that there were no material changes in the research and development activities and reports research and development expenses of ¥112.854 million for the six-month period. - FY2022-Q1RestatedAnnual report
「Research and development expenses for the three-month period were ¥69.495 million. There were no material changes in the Company's research and development activities during the three-month period.」
The filing states that there were no material changes in the research and development activities and that research and development expenses for the quarter were ¥69.495 million. - FY2021AdvancedAnnual report
「Development of quantum dot devices for LiDAR: Completed the initial prototype of a quantum dot semiconductor optical amplifier for LiDAR that can be implemented in silicon photonics.」
The Company incurred research and development expenses of ¥180.154 million, with progress including completion of prototypes and functional integration for quantum dot devices for LiDAR, a four-wavelength integrated module and optometry equipment. - FY2021-Q3First statedAnnual report
「Research and development expenses for the nine-month period were ¥97.049 million. There were no material changes in the Company's research and development activities during the nine-month period.」
The filing states that research and development expenses for the nine-month period were ¥97.049 million and that there were no material changes in the activities.